Long-term Health Outcomes of New Persistent Opioid Use After Gastrointestinal Cancer Surgery
Mujtaba Khalil(University of Wisconsin–Madison), Timothy M. Pawlik(The Ohio State University), Susan Tsai(The Ohio State University Wexner Medical Center), Yutaka Endo(University of Rochester Medical Center), Erryk Katayama(The Ohio State University), Selamawit Woldesenbet(The Ohio State University Wexner Medical Center), Muhammad Muntazir Mehdi Khan(Allegheny Health Network), Zayed Rashid(The Ohio State University Wexner Medical Center), Muhammad Musaab Munir(The Ohio State University Wexner Medical Center), Abdullah Altaf(The Ohio State University Wexner Medical Center), Mary Dillhoff(The Ohio State University Wexner Medical Center)
Cited by 15
Related Papers
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas
|Nature Genetics|2013|709
Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models
|BMC Cancer|2018|391
Plasma extracellular RNA profiles in healthy and cancer patients
|Scientific Reports|2016|294
Circulating giant macrophages as a potential biomarker of solid tumors
|Proceedings of the National Academy of Sciences|2014|281